The COVID-19 Pandemic has impacted the field of kidney health immensely, shaping research in both the short term and long term. It has become increasingly important to try and protect vulnerable patients, such as patients with kidney disease or transplantation, who are much more likely to suffer the negative effects of infection. COVID-19 infection has also brought with it an unexpected, increased risk of developing kidney disease and Acute Kidney Injury in those who are hospitalized.
The aim of this Research Topic is to highlight recent advances in the field including those that shed light onto the direct and indirect causes of acute kidney injury as a consequence of COVID-19 infection. Chronic Kidney Disease is already a common and life threatening condition; the effect of COVID-19 on sufferers is key to the outcomes of these patients. The pandemic has put a strain on the limited resources in healthcare systems across the world, such as oversubscription to dialysis machines.
Our goal is to overall increase the quality of life and reduce the risk of adverse COVID-19 outcomes by Clinical and basic research and to sculpt treatment of patients to alleviate the stress on our healthcare systems. We also welcome discussion on the future of COVID-19 and Nephrology and reviews on how we have handled the pandemic so far.
This Research Topic covers, but is not limited to:
• Biostatistics of COVID-19 in patients suffering from a kidney issue.
• AKI and COVID-19
• Dialysis and COVID-19
• CKD and COVID-19
• Treatment and management of COVID-19 in patients suffering from a kidney issue
• Comparison of the "efficacy" of different SARS-COV2 vaccination regimes (i.e. homologous and non-homologous) in dialysis and CKD patients.
• Predictive model related to SARS-COV2 infection in dialysis and CKD patients.
• immunoglobulin dynamics after SARS-COV2 vaccination in dialysis and CKD patients
The COVID-19 Pandemic has impacted the field of kidney health immensely, shaping research in both the short term and long term. It has become increasingly important to try and protect vulnerable patients, such as patients with kidney disease or transplantation, who are much more likely to suffer the negative effects of infection. COVID-19 infection has also brought with it an unexpected, increased risk of developing kidney disease and Acute Kidney Injury in those who are hospitalized.
The aim of this Research Topic is to highlight recent advances in the field including those that shed light onto the direct and indirect causes of acute kidney injury as a consequence of COVID-19 infection. Chronic Kidney Disease is already a common and life threatening condition; the effect of COVID-19 on sufferers is key to the outcomes of these patients. The pandemic has put a strain on the limited resources in healthcare systems across the world, such as oversubscription to dialysis machines.
Our goal is to overall increase the quality of life and reduce the risk of adverse COVID-19 outcomes by Clinical and basic research and to sculpt treatment of patients to alleviate the stress on our healthcare systems. We also welcome discussion on the future of COVID-19 and Nephrology and reviews on how we have handled the pandemic so far.
This Research Topic covers, but is not limited to:
• Biostatistics of COVID-19 in patients suffering from a kidney issue.
• AKI and COVID-19
• Dialysis and COVID-19
• CKD and COVID-19
• Treatment and management of COVID-19 in patients suffering from a kidney issue
• Comparison of the "efficacy" of different SARS-COV2 vaccination regimes (i.e. homologous and non-homologous) in dialysis and CKD patients.
• Predictive model related to SARS-COV2 infection in dialysis and CKD patients.
• immunoglobulin dynamics after SARS-COV2 vaccination in dialysis and CKD patients